Labs / Assays & in vitro testing
Invenra
Madison, WI, United States · invenra.com
Invenra develops and characterizes monoclonal, bispecific, and trispecific antibodies for drug discovery and development. It works with biotech and other research teams on discovery, expression, validation, and partnership programs, based in Madison, Wisconsin, United States.
They take quote requests through a form on their website with project details. Their quote form
What they offer
Monoclonal antibody discovery
Produces fully human mAb leads with binding properties, developability data, and functional validation.
B-Body bispecific discovery
Screens bispecific combinations in final therapeutic format and delivers lead candidates ready for cell line development.
B-Body bispecific expression
Expresses and purifies customer-provided sequences as B-Body bispecific antibodies.
T-Body trispecific discovery
Develops trispecific antibody candidates for three-target engagement in a custom partnership model.
Characterization and validation
Provides functional immunology, biophysical developability, and binding data for molecules at any stage.
ADC program support
Supports antibody-drug conjugation-compatible platform work and ADC-related development.
What they work on
- Modalities
- Antibody, Bispecific, ADC
- Species and models
- human phage libraries, CHO cells
- Assays and studies
- cross-reactivity testing, affinity (KD) measurements, cell-based functional screening, binding kinetics, epitope diversity, validated cell binding analysis, in silico liability scanning, mass spectrometry intact mass confirmation, developability assays, formulation optimization, thermal stability, self-association, and 3 more
- Instruments and platforms
- Carterra LSA
- Scale and capacity
- 30+ proprietary human phage libraries, 288+ bispecific combinations, 50 mL expression, 200 mL expression, 500 mL expression
- Therapeutic areas
- cancer, immuno-oncology
- Turnaround
- ≤ 12 wks · 4 months from binder to lead candidates · 4-8 weeks from DNA to purified antibody
- What to send
- antigen · purified recombinant antigens · cell lines · VH/VL sequences for each binding arm · target biology and program goals
- Minimums and prices
- $100K starting price for mAb Discovery · $200K starting price for B-Body Discovery · $3,750 per molecule for B-Body Expression
- Type
- CRDMO
- Sites
- Madison, United States
- Address
- 5510 Element Way Suite 400 Madison, WI 53719
Similar labs. Sparx BIO, AbTherx, Aurigene Pharmaceutical Services, GlycoNex, Inc.
Found in a contract services directory. Listing built from invenra.com. Work here? Claim this listing.